CureSCA12

About SCA12

Understanding SCA12 (Spinocerebellar Ataxia Type 12)

A clear introduction for people living with SCA12, their families, and anyone trying to understand the condition properly.

At a glance

SCA12 in five facts

The figures people search for, with the caveat each one needs. Every number below is taken from the sources on this page, and none of them predicts how the condition will affect any one person.

How many CAG repeats?

TypicalGrey zoneAssociated with SCA12 43 — threshold proposed by AIIMS / CSIR-IGIB, 2017 01020304050607080 CAG repeats in the PPP2R2B gene
Most people have under about 30 repeats — the National Ataxia Foundation gives 4–31 as typical. SCA12 is generally associated with more than about 50; the classic range in affected families is 51–78. Between those is a grey zone: NAF says 32–49 is “not clear” on current data, and the 2026 review reports patients at 43–50 and rarely 40–42, concluding that a strict cutoff “has not been universally established”. The 2017 Indian study proposed 43. A result in that range needs a genetics service, not this chart. Repeat number alone does not predict how the condition will affect any individual.

Sources National Ataxia Foundation · Review, 2026 · Srivastava et al., Brain 2017

When do symptoms usually start?

ReportedMost oftenReported 01020304050607080 age in years
Symptoms most often begin between 30 and 50, and have been reported as young as 8 and as late as 70. GeneReviews summarises it as action tremor in the fourth decade; Indian cohorts report average onset in the mid-40s to early 50s. Age alone neither confirms nor rules out SCA12.

Sources National Ataxia Foundation · GeneReviews · Review, 2026

50%

chance for each child of an affected parent

It applies separately to every child — not a quota, so it does not mean half of any family will be affected. And inheriting the change is not the same as certainly developing symptoms: how fully it shows varies, especially with repeat counts in the grey zone.

Sources National Ataxia Foundation · Review, 2026

8–9 in 100

of inherited dominant ataxias in North India

From the largest Indian screening study, which found SCA12 in 8.6% of its ataxia referrals — the commonest type it saw. A widely quoted 16% comes from a much smaller study; the 2026 review says to read it with caution. Worldwide, Orphanet classes SCA12 at fewer than 1 person in a million.

Sources Sharma et al., 2022 · Global review, 2025 · National Ataxia Foundation · Orphanet

None yet

treatment that slows or stops SCA12

There is no cure, and nothing yet slows or stops the condition itself — the 2026 review states this plainly. Symptom treatments exist — NAF lists physiotherapy, occupational therapy, speech therapy and mental-health support — and a randomised trial in 2026, the first in SCA12, tested a medicine for the tremor and reported a benefit. What suits any one person is a conversation with a neurologist; we do not recommend treatments here.

Sources National Ataxia Foundation · Propranolol trial, 2026 · Review, 2026

SCA12 usually progresses very slowly, and the National Ataxia Foundation states that lifespan is generally not shortened by the disease. Everyone’s course is different; this is context, not a forecast. Source · What progression usually looks like

Spinocerebellar Ataxia Type 12 is a rare inherited neurological condition. It affects coordination, balance, and movement, because it involves progressive changes in the cerebellum — the part at the back of the brain that coordinates movement — and in related regions.

Cerebrum Cerebellum front
The cerebellum sits at the back of the brain, underneath the cerebrum. It coordinates movement and balance, which is why SCA12 affects those first. Imaging in SCA12 often shows other regions involved too.

Sources National Ataxia Foundation · NIMHANS cohort, 2022

SCA12 is caused by a change in the PPP2R2B gene. It is one of a group of conditions called the spinocerebellar ataxias. They look similar in some ways, but each has a different genetic cause.

Experience varies a great deal from person to person, including within the same family. Everything linked below is a starting point for a conversation with a neurologist or other qualified clinician — not a diagnosis, and not a treatment plan.

Read more

Go deeper on any part of this

Symptoms and progression

Tremor, balance, walking, speech, mood and memory effects, and how SCA12 usually unfolds over time.

Read

Gene, inheritance and ancestry

The PPP2R2B gene, the CAG repeat, autosomal dominant inheritance, genetic counselling, and why SCA12 clusters in one community.

Read

How SCA12 is diagnosed

The four things a diagnosis usually involves, and the one that confirms it.

Read

Treatment today

There is no cure yet. What exists is help with individual symptoms — and one 2026 trial.

Read

You are not the only one

Connect with others who understand SCA12

Reading about a condition and speaking to someone living with it are two very different things. Both help.

Join us